Advertisement

Index by author

March 01, 2003; Volume 31,Issue 3

A

  1. Abraham, Trent L.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  2. Ahnoff, Martin

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

B

  1. Baron, Gabriel

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  2. Bertelsen, Kirk M.

    1. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289

  3. Bonifácio, M. J.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

  4. Boobis, Alan R.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  5. Bowers, G.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

  6. Brandt, Ingvar

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259

  7. Bredberg, Ulf

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  8. Brittebo, Eva B.

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259

C

  1. Cazali, N.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

  2. Chen, Cuiping

    1. P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
      Cuiping Chen, Elizabeth Hanson, John W. Watson and Jae S. Lee
      Drug Metabolism and Disposition March 2003, 31 (3) 312-318; DOI: https://doi.org/10.1124/dmd.31.3.312

  3. Cherrington, N. J.

    1. Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
      M. K. Shelby, N. J. Cherrington, N. R. Vansell and C. D. Klaassen
      Drug Metabolism and Disposition March 2003, 31 (3) 326-333; DOI: https://doi.org/10.1124/dmd.31.3.326

  4. Cresteil, T.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

  5. Czeskis, Boris

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

D

  1. Dromer, Françoise

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

E

  1. Edwards, Robert J.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  2. Ericsson, Hans

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  3. Eriksson, Ulf G.

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

F

  1. Fager, Gunnar

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  2. Fernandez, Christine

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  3. Forkert, Poh-Gek

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

G

  1. Gabrielsson, Margareth

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  2. Gantier, Jean Charles

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  3. Gemma, Simonetta

    1. Metabolism of Chloroform in the Human Liver and Identification of the Competent P450s
      Simonetta Gemma, Luciano Vittozzi and Emanuela Testai
      Drug Metabolism and Disposition March 2003, 31 (3) 266-274; DOI: https://doi.org/10.1124/dmd.31.3.266

  4. Gimenez, François

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  5. Gislén, Kristina

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  6. Granberg, Lizette

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259

  7. Greenblatt, David J.

    1. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289

  8. Gustafsson, David

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

H

  1. Hanson, Elizabeth

    1. P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
      Cuiping Chen, Elizabeth Hanson, John W. Watson and Jae S. Lee
      Drug Metabolism and Disposition March 2003, 31 (3) 312-318; DOI: https://doi.org/10.1124/dmd.31.3.312

  2. He, Minxia M.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  3. Hoffmann, Kurt-Jürgen

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

I

  1. Imbert, Frédéric

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  2. Isin, Emre M.

    1. Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation Pathway
      Amit S. Kalgutkar, Timothy J. Taylor, Karthik Venkatakrishnan and Emre M. Isin
      Drug Metabolism and Disposition March 2003, 31 (3) 243-249; DOI: https://doi.org/10.1124/dmd.31.3.243

J

  1. Jardin, Méryam

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

K

  1. Kalgutkar, Amit S.

    1. Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation Pathway
      Amit S. Kalgutkar, Timothy J. Taylor, Karthik Venkatakrishnan and Emre M. Isin
      Drug Metabolism and Disposition March 2003, 31 (3) 243-249; DOI: https://doi.org/10.1124/dmd.31.3.243

  2. Klaassen, C. D.

    1. Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
      M. K. Shelby, N. J. Cherrington, N. R. Vansell and C. D. Klaassen
      Drug Metabolism and Disposition March 2003, 31 (3) 326-333; DOI: https://doi.org/10.1124/dmd.31.3.326

L

  1. Lake, Brian G.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  2. Lash, Lawrence

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

  3. Learmonth, D. A.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

  4. Lee, Jae S.

    1. P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
      Cuiping Chen, Elizabeth Hanson, John W. Watson and Jae S. Lee
      Drug Metabolism and Disposition March 2003, 31 (3) 312-318; DOI: https://doi.org/10.1124/dmd.31.3.312

  5. Lindsay, Thomas J.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  6. Loureiro, A. I.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

M

  1. Mentre, France

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  2. Mitchell, Malcolm I.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  3. Moussa, Madeleine

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

O

  1. Obach, R. Scott

    1. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289
    2. Verification of the Selectivity of (+)N-3-Benzylnirvanol as a CYP2C19 Inhibitor
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition March 2003, 31 (3) 343; DOI: https://doi.org/10.1124/dmd.31.3.343

  2. Oliver, Stuart D.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  3. Östergren, Anna

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259

P

  1. Palma, P. N.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

  2. Payne, Chris

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  3. Pons, G.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

  4. Pouliquen, Isabelle J.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  5. Price, Roger J.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

R

  1. Renwick, Anthony B.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  2. Rey, E.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

S

  1. Schaefer, Hans C.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  2. Shelby, M. K.

    1. Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
      M. K. Shelby, N. J. Cherrington, N. R. Vansell and C. D. Klaassen
      Drug Metabolism and Disposition March 2003, 31 (3) 326-333; DOI: https://doi.org/10.1124/dmd.31.3.326

  3. Shipley, Lisa A.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  4. Singlas, Eric

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  5. Soares-da-Silva, P.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

  6. Sonnier, M.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

T

  1. Tanphaichitr, Nongnuj

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

  2. Tardif, Robert

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

  3. Taylor, Timothy J.

    1. Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation Pathway
      Amit S. Kalgutkar, Timothy J. Taylor, Karthik Venkatakrishnan and Emre M. Isin
      Drug Metabolism and Disposition March 2003, 31 (3) 243-249; DOI: https://doi.org/10.1124/dmd.31.3.243

  4. Testai, Emanuela

    1. Metabolism of Chloroform in the Human Liver and Identification of the Competent P450s
      Simonetta Gemma, Luciano Vittozzi and Emanuela Testai
      Drug Metabolism and Disposition March 2003, 31 (3) 266-274; DOI: https://doi.org/10.1124/dmd.31.3.266

  5. Thuresson, Anneli

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  6. Tredger, J. Michael

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  7. Tréluyer, J. M.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

V

  1. van Beijsterveldt, Ludy

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  2. Vandevoort, Catherine

    1. Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
      Poh-Gek Forkert, Lawrence Lash, Robert Tardif, Nongnuj Tanphaichitr, Catherine Vandevoort and Madeleine Moussa
      Drug Metabolism and Disposition March 2003, 31 (3) 306-311; DOI: https://doi.org/10.1124/dmd.31.3.306

  3. Vansell, N. R.

    1. Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
      M. K. Shelby, N. J. Cherrington, N. R. Vansell and C. D. Klaassen
      Drug Metabolism and Disposition March 2003, 31 (3) 326-333; DOI: https://doi.org/10.1124/dmd.31.3.326

  4. Venkatakrishnan, Karthik

    1. Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation Pathway
      Amit S. Kalgutkar, Timothy J. Taylor, Karthik Venkatakrishnan and Emre M. Isin
      Drug Metabolism and Disposition March 2003, 31 (3) 243-249; DOI: https://doi.org/10.1124/dmd.31.3.243
    2. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289

  5. Vittozzi, Luciano

    1. Metabolism of Chloroform in the Human Liver and Identification of the Competent P450s
      Simonetta Gemma, Luciano Vittozzi and Emanuela Testai
      Drug Metabolism and Disposition March 2003, 31 (3) 266-274; DOI: https://doi.org/10.1124/dmd.31.3.266

  6. von Moltke, Lisa L.

    1. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289

W

  1. Walsky, Robert L.

    1. Verification of the Selectivity of (+)N-3-Benzylnirvanol as a CYP2C19 Inhibitor
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition March 2003, 31 (3) 343; DOI: https://doi.org/10.1124/dmd.31.3.343

  2. Watson, John W.

    1. P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
      Cuiping Chen, Elizabeth Hanson, John W. Watson and Jae S. Lee
      Drug Metabolism and Disposition March 2003, 31 (3) 312-318; DOI: https://doi.org/10.1124/dmd.31.3.312

  3. Watts, Patricia S.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  4. Wright, L. C.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250
Back to top

In this issue

Advertisement